Paritosh Pande

Associate Principal Scientist, Sterile Drug Product Commercialization Merck & Co.

Dr. Paritosh Pande is an Associate Principal Scientist and technical lead in the Sterile Drug Product Commercialization group at Merck, West Point, PA, where he supports late-stage commercialization of biologics. He joined Merck in 2021 as an Associate Director to lead lyophilization platform technology for vaccine manufacturing and, since 2024, has focused on advancing ADC programs by evaluating key variables that impact the scalability of vial fogging across manufacturing sites. He is the lyo lead for Merck at BioPhorum Operations Group, active member of LyoHUB consortium and co-leads Merck’s
Lyophilization Community of Practice focused on promoting industry best practices for development, scale-up and technology transfer of parenteral injectable drug products.

Seminars

Monday 12th October 2026
Leveraging Novel Process & Technology Options to Optimize Vial Fogging Challenges in ADC DP Manufacturing
  • Highlighting the importance of optimizing container selection and process levers to optimize ADC DP lyophilization
  • Optimizing ADC DP manufacturing process to reduce challenges with vial fogging through hydrophobic vial technology
  • Showcasing learnings within ADC manufacturing control strategy
Paritosh Pande